No article text was recorded for this version.
preclinical disease identification
Version 1 of 123 papers24 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Entorhinal‐based path integration selectively predicts midlife risk of Alzheimer's disease
- Blog: Alzheimer’s Disease Projection From Normal to Mild Dementia Reflected in Functional Network Connectivity: A Longitudinal Study
- Blog: An analysis of eye-movements during reading for the detection of mild cognitive impairment
- Blog: Quantification of Cognitive Function in Alzheimer’s Disease Based on Deep Learning
- Blog: Altered Patterns of Phase Position Connectivity in Default Mode Subnetwork of Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment
- Blog: Unveiling Early Signs of Preclinical Alzheimer's Disease Through ERP Analysis with Weighted Visibility Graphs and Ensemble Learning.
- Blog: Prediction of 7‐year's conversion from subjective cognitive decline to mild cognitive impairment
- Blog: Prediction of Possible conversion from MCI to AD using Machine learning
- Blog: The Biomarkers for Identifying Preclinical Alzheimer's Disease via Structural and Functional Magnetic Resonance Imaging
- Blog: A novel biomarker of amnestic MCI based on dynamic cross-frequency coupling patterns during cognitive brain responses
- Blog: Disrupted brain networks underlying high‐fidelity memory retrieval in subjective cognitive decline: A task‐based fMRI study
- Blog: Penalized logistic regression using functional connectivity as covariates with an application to mild cognitive impairment
- Blog: Developing Measures of Cognitive Impairment in the Real World from Consumer-Grade Multimodal Sensor Streams
- Blog: Temporal order of Alzheimer’s disease-related cognitive marker changes in BLSA and WRAP longitudinal studies
- Blog: Deep Feature Selection and Causal Analysis of Alzheimer’s Disease
- Blog: A Predictive Visual Analytics System for Studying Neurodegenerative Disease Based on DTI Fiber Tracts
- Blog: Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
- Blog: Unleashing the Power of Digital Voice for Early Symptom Detection for Alzheimer's Disease and Related Dementias
- Blog: Cognition, Brain Atrophy, and Cerebrospinal Fluid Biomarkers Changes from Preclinical to Dementia Stage of Alzheimer's Disease and the Influence of Apolipoprotein E
- Blog: Detecting Alzheimerâs Disease Using Gated Convolutional Neural Network from Audio Data
- Blog: Pervasive embedded real time monitoring of EEG and SpO2
- Blog: Hippocampus Radiomic Biomarkers for the Diagnosis of Amnestic Mild Cognitive Impairment: A Machine Learning Method
- Blog: Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_preclinical_disease_identification_10136f4d,
title = {preclinical disease identification},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/preclinical-disease-identification/rdr_10136f4d52df48c49a4f43d64e8c91ce},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_preclinical_disease_identification_10136f4d_v1,
title = {preclinical disease identification},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/preclinical-disease-identification/rdr_10136f4d52df48c49a4f43d64e8c91ce/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}